Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2008 | 01-2008 | 10-2007 | 07-2007 | 04-2007 | |
| Sales | 393,200 | 329,100 | 284,100 | 346,100 | 349,300 |
| Cost of Goods | 251,700 | 208,700 | 170,400 | 232,500 | 228,900 |
| Gross Profit | 141,500 | 120,400 | 113,700 | 113,600 | 120,400 |
| Operating Expenses | 108,400 | 103,100 | 92,100 | 99,700 | 86,900 |
| Operating Income | 33,800 | 18,000 | 22,000 | 14,400 | 34,400 |
| Other Income | -15,900 | -44,900 | -21,500 | 5,000 | 61,700 |
| Pre-tax Income | 17,900 | -26,900 | 500 | 19,400 | 96,100 |
| Income Tax | 1,900 | 1,500 | -2,500 | 2,000 | 2,700 |
| Net Income Continuous | 16,000 | -28,400 | 3,000 | 17,400 | 93,400 |
| Net Income Discontinuous | 300 | 1,100 | -9,000 | -800 | -1,300 |
| Net Income | $16,300 | $-27,300 | $-6,000 | $16,600 | $92,100 |
| EPS Basic Total Ops | 0.14 | -0.23 | -0.05 | 0.14 | 0.79 |
| EPS Basic Continuous Ops | 0.14 | -0.24 | 0.02 | 0.15 | 0.80 |
| EPS Basic Discontinuous Ops | 0.00 | 0.01 | -0.07 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.14 | -0.23 | 0.02 | 0.14 | 0.72 |
| EPS Diluted Continuous Ops | 0.14 | -0.24 | 0.08 | 0.15 | 0.73 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.01 | -0.06 | -0.01 | -0.01 |
| EBITDA(a) | $54,900 | $-24,600 | $57,300 | $66,900 | $51,500 |